Elevated immunogenicity of tumor cells could lead to a relevant immune response that causes a lower pT stage and fewer metastases although a fraction of these tumors upregulate PD-L1 in an attempt to evade the immune response (summarized in [59]). The gene discussed is CD274; the disease is neoplasm.